RE: The coming year ahead will be truly transformational for Omega15 Apr 2021 13:14
"If you cannot wait a relatively short time, then you should just give up investing IMO."
September 7th 2020
"Omega remains on track to have production capacity in place this month to produce an initial 100,000 AbC-19™ Rapid test per week, scaling up to 200,000 tests per week capacity in October. If demand through the UK-RTC was to go above 200,000 tests per week, either from the UK Government, or from other third parties, the Company would allocate additional capacity to meet that demand as well"
September 7th 2020
“We’re very pleased that the self-test usability study has completed and that we are progressing towards our goal of MHRA approval for self-test home use. We cannot give a timescale for when this might be achieved but we look forward to updating shareholders on further developments.”
6th October 2020
The UK-RTC members are in the final stages of formalising an agreement for the supply of goods from members to Abingdon Health, following the Memorandum of Understanding that was signed in April 2020. Omega expects to manufacture approximately 175,000 of these first 1 million tests but over the term of this supply agreement, Omega will manufacture not less than 25% of the demand from total orders placed, either from the UK Government or, where allowed, third party customers"
19th October
"Omega’s production capacity for AbC-19™ Rapid tests is currently 100,000 tests a week and the Company expects this to reach 200,000 tests by the end of November"
28th October
"The Company is optimistic that it will see further orders materialise from DHSC and other sources, both domestic and overseas, in the second half of the current financial year."
Lets hope its "truly transformational" as they couldn't screw it up much more
InColinWeTrust
Sign In
Follow the stocks
